Director/PDMR Shareholding

RNS Number : 5236D
Reed Elsevier PLC
29 April 2013
 



 

 

ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV

 

29 April 2013

 

 

Director/PDMR Shareholdings

 

Reed Elsevier announces that it today received notification of the following transactions in the securities of Reed Elsevier by Erik Engstrom, Director and Ian Fraser, PDMR:

 

 

(a) Reed Elsevier Group plc Bonus Investment Plan 2010 ("BIP")

 

Vesting of matching shares

 

In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the BIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom and Ian Fraser after taking account of shares withheld to meet personal tax and social security obligations.

 


No. of Reed Elsevier PLC ordinary shares/ADRs* vested

No. of Reed Elsevier NV ordinary shares/ADRs* vested

No. of Reed Elsevier PLC ordinary shares/ADRs* released

No. of Reed Elsevier NV ordinary shares/ADRs* released

Director





Erik Engstrom


62,819*


33,294*






PDMR





Ian Fraser

38,163


20,226




24,939


13,217

 

*Denotes vesting/release of ADRs.  Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.

 

The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share, €13.15 per Reed Elsevier NV ordinary share and $34.06 per Reed Elsevier NV ADR.

 

(b) Reed Elsevier Group plc Long Term Incentive Plan ("LTIP")

 

Vesting of performance shares

 

In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the LTIP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Ian Fraser after taking account of shares withheld to meet personal tax and social security obligations.

 


No. of Reed Elsevier PLC ordinary shares vested

No. of Reed Elsevier NV ordinary shares vested

No. of Reed Elsevier PLC ordinary shares released

No. of Reed Elsevier NV ordinary shares released

PDMR





Ian Fraser

44,795


23,741




29,416


15,590

 

The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share and €13.15 per Reed Elsevier NV ordinary share. 

 

(c) Reed Elsevier Group plc Growth Plan 2010 ("REGP")

 

Vesting of performance shares

 

In connection with the vesting on 25 April 2013 of the share awards granted in May 2010 under the REGP, the table below shows the total numbers of shares which vested and the numbers of shares actually released to Erik Engstrom after taking account of shares withheld to meet personal tax and social security obligations.

 


No. of Reed Elsevier PLC ordinary shares vested

No. of Reed Elsevier NV ordinary shares vested

No. of Reed Elsevier PLC ordinary shares released

No. of Reed Elsevier NV ordinary shares released

Director





Erik Engstrom

214,855

141,093

113,873

74,779

 

The closing market price of each security on the date of vesting was £7.76 per Reed Elsevier PLC ordinary share and €13.15 per Reed Elsevier NV ordinary share.

 

In addition, an equal number of performance shares became deferred performance shares, subject to release in 2015 (see notification below regarding the grant of matching shares).

 

Grant of matching shares

 

In accordance with the REGP rules, the following grant of matching shares was made to Erik Engstrom on 25 April 2013.

 


No. of Reed Elsevier PLC ordinary shares

No. of Reed Elsevier PLC ADRs

No. of Reed Elsevier NV ordinary shares

No. of Reed Elsevier NV ADRs

Director





Erik Engstrom

304,891

4,251

400,980

24,757

 

The number of matching shares awarded is determined in accordance with the REGP rules and is equal to the deferred performance shares (see notification immediately above) plus Mr Engstrom's 300% of base salary personal shareholding he invested to participate in the REGP.

 

The number of matching shares which may actually vest will be determined by three separate performance measures - Relative Total Shareholder Return measures (TSR measure), a Return on Invested Capital measure (ROIC) and an adjusted Earnings Per Share measure (EPS measure) measured over financial years 2013 and 2014 - and is subject to the overall plan cap.

 

 

(d) Reed Elsevier Group plc Long Term Incentive Share Option Scheme ("LTIS") and Reed Elsevier Group plc Share Option Scheme ("ESOS"): Exercise of Options

 

The following options to acquire Reed Elsevier shares were exercised by Erik Engstrom and Ian Fraser on 29 April 2013.

 

 


Date of grant

Plan name

No. of Reed Elsevier PLC ordinary shares

No. of Reed Elsevier NV ordinary shares

Option price per share

Director






Erik Engstrom

23 August 2004

LTIS

325,163


£4.78


23 August 2004

LTIS


224,766

€10.30


23 August 2004

ESOS

63,460


£4.78


23 August 2004

ESOS


43,866

€10.30







PDMR






Ian Fraser

18 November 2005

LTIS


61,350

€11.35


13 March 2006

ESOS

52,747


£5.305


13 March 2006

ESOS


39,240

€11.47


19 February 2009

ESOS

54,305


£5.42


19 February 2009

ESOS


35,261

€9.415

 

 

 

(e) Sale of shares

 

On 29 April 2013, Erik Engstrom and Ian Fraser sold the following shares set out below.

 

 


No. of Reed Elsevier PLC ordinary shares/ADRs* sold

Price per Reed Elsevier PLC ordinary shares/ADRs**

No. of Reed Elsevier NV ordinary shares/ADRs* sold

Price per Reed Elsevier NV ordinary shares/ADRs**

Director





Erik Engstrom

498,996

£7.531127

341,211

€12.8101




33,294*

$33.5316**






PDMR





Ian Fraser

151,019

£7.531127

164,658

€12.8241











 

*Denotes sale of ADRs.  Each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.

** Denotes price per ADR

 

 

Following these transactions, the current interests of Erik Engstrom in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:

 

Reed Elsevier PLC         110,540 ordinary shares

Reed Elsevier NV           511,756 ordinary shares

 

 

Note: The Reed Elsevier 2012 Directors' Remuneration Report is available to view or download at Reed Elsevier's website www.reedelsevier.com.

 

- ENDS -

 

 

 

 

Enquiries

 

Paul Abrahams (Media)                                     
+44 20 7166 5724                                             

 
Colin Tennant (Investors)

+44 20 7166 5751

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEUFMUFDSESL

Companies

Relx plc (REL)
UK 100

Latest directors dealings